UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction

Genes & development, 2013-06, Vol.27 (12), p.1351-1364

2013

Volltextzugriff (PDF)

Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration

Nature cell biology, 2012-06, Vol.14 (6), p.575

2012

Volltextzugriff (PDF)

PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation

Blood, 2019-10, Vol.134 (14), p.1176-1189

2019

Volltextzugriff (PDF)

Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (6), p.1113-1123

2019

Volltextzugriff (PDF)

Indicators of responsiveness to immune checkpoint inhibitors

Scientific reports, 2017-04, Vol.7 (1), p.807-12, Article 807

2017

Volltextzugriff (PDF)

Evolved histone tail regulates 53BP1 recruitment at damaged chromatin

Nature communications, 2024-05, Vol.15 (1), p.4634-14, Article 4634

2024

Volltextzugriff (PDF)

Dynamic holographic optical tweezers

Optics communications, 2002-06, Vol.207 (1), p.169-175

2002

Volltextzugriff (PDF)

Ubiquitin-Independent Degradation of Antiapoptotic MCL-1

Molecular and Cellular Biology, 2010-06, Vol.30 (12), p.3099-3110

2010

Volltextzugriff (PDF)

255 Functional and multi-omic characterization of CAR T cells across healthy donors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A294-A294

2023

Volltextzugriff (PDF)

536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A610-A610

2023

Volltextzugriff (PDF)

1020 Proteomic analysis of T cell exhaustion unveils differential modulation of the DNA damage response

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1128-A1128

2023

Volltextzugriff (PDF)

CRISPR/dCas9-KRAB-Mediated Suppression of S100b Restores p53-Mediated Apoptosis in Melanoma Cells

Cells (Basel, Switzerland), 2023-02, Vol.12 (5), p.730

2023

Volltextzugriff (PDF)

1211 Defining the role of PCK2 in T cell metabolic plasticity in Glioblastoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1335-A1335

2023

Volltextzugriff (PDF)

304 Discovering T cell proteome turnover dynamics to enhance persistence in solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A347-A347

2023

Volltextzugriff (PDF)

CAR-T Therapies in Solid Tumors: Opportunities and Challenges

Current oncology reports, 2023-05, Vol.25 (5), p.479-489

2023

Volltextzugriff (PDF)

Effect of Sulforaphane and 5-Aza-2'-Deoxycytidine on Melanoma Cell Growth

Medicines (Basel, Switzerland), 2019-06, Vol.6 (3), p.71

2019

Volltextzugriff (PDF)

Abstract 1892: Proteomic interrogation of the metabolic control of MHC class I antigen presentation in metastatic melanoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1892-1892

2021

Volltextzugriff (PDF)

Role of NEK2 in tumorigenesis and tumor progression

Trends in molecular medicine, 2024-08

2024

Volltextzugriff (PDF)

Abstract B26: Combinational effect of sulforaphane (SFN) and epigenetic demethylation agent 5-aza-2’-deoxycytidine (DAC) on metastatic melanoma

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19_Supplement), p.B26-B26

2020

Volltextzugriff (PDF)

Abstract 1577: Caloric restriction mimetics as adjuvant to immune checkpoint inhibitors for treatment of melanoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1577-1577

2021

Volltextzugriff (PDF)

Optical peristalsis

Applied physics letters, 2003-06, Vol.82 (22), p.3985-3987

2003

Volltextzugriff (PDF)

Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia

Cancer science, 2024-03, Vol.115 (3), p.963-973

2024

Volltextzugriff (PDF)

Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma

Molecular immunology, 2023-11, Vol.163, p.188-195

2023

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways

Immunity (Cambridge, Mass.), 2014-12, Vol.41 (6), p.947-959

2014

Volltextzugriff (PDF)

Abstract 2037: E-cadherin enhances immune control of metastatic melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2037-2037

2018

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(92)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction

Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration

PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation

Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma

Indicators of responsiveness to immune checkpoint inhibitors

Evolved histone tail regulates 53BP1 recruitment at damaged chromatin

Dynamic holographic optical tweezers

Ubiquitin-Independent Degradation of Antiapoptotic MCL-1

255 Functional and multi-omic characterization of CAR T cells across healthy donors

536 EZH2 senses metabolic stress to restore MHC-I antigen presentation and ICB response in metastatic melanoma

1020 Proteomic analysis of T cell exhaustion unveils differential modulation of the DNA damage response

CRISPR/dCas9-KRAB-Mediated Suppression of S100b Restores p53-Mediated Apoptosis in Melanoma Cells

1211 Defining the role of PCK2 in T cell metabolic plasticity in Glioblastoma

304 Discovering T cell proteome turnover dynamics to enhance persistence in solid tumors

CAR-T Therapies in Solid Tumors: Opportunities and Challenges

Effect of Sulforaphane and 5-Aza-2'-Deoxycytidine on Melanoma Cell Growth

Abstract 1892: Proteomic interrogation of the metabolic control of MHC class I antigen presentation in metastatic melanoma

Role of NEK2 in tumorigenesis and tumor progression

Abstract B26: Combinational effect of sulforaphane (SFN) and epigenetic demethylation agent 5-aza-2’-deoxycytidine (DAC) on metastatic melanoma

Abstract 1577: Caloric restriction mimetics as adjuvant to immune checkpoint inhibitors for treatment of melanoma

Optical peristalsis

Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia

Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma

Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways

Abstract 2037: E-cadherin enhances immune control of metastatic melanoma

Suchergebnisse filtern